Ocular Oncology and Pathology focuses on benign and malignant lesions involving the eye, orbit, eyelids, and surrounding tissues. The session connects clinical diagnosis with pathology, imaging, molecular characterization, biomarkers, medical and surgical treatment, radiation therapy, and evolving strategies for preserving vision and improving cancer outcomes.
Abstract Scope and Participation
Submissions may explore ocular tumors, orbital and eyelid malignancies, pathology, tumor imaging, biomarkers, molecular diagnostics, treatment approaches, prognosis, and survivorship. Ophthalmic oncologists, pathologists, ophthalmologists, researchers, radiation specialists, medical oncologists, and multidisciplinary cancer-care professionals are encouraged to participate.







Title : Why a paediatric orthoptic oncology service matters
Shenika Tailor, University Hospitals of Leicester NHS Trust, United Kingdom
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom